Dashboard
Discussions
Watchlists
Collections
Tools
More
Events
𝛼
SK
or Search
SIGN UP
SIGN IN
ENTITY
Resmed Inc (RMD US)
Watchlist
80
Analysis
Health Care
•
United States
ResMed Inc. develops, manufactures, and markets medical equipment for the treatment of sleep disordered breathing. The Company sells diagnostic and treatment devices in various countries through its subsidiaries and independent distributors.
more
Watchlist
All
Insights
Primers
Broker
Sponsored
Syndicated
Podcast
Buy side
Refresh
Focused
Suggested
bullish
•
Cross Asset Strategy
•
20 Feb 2019 07:43
Aussie Reporting Season Update: February 2019
The Banks remain under earnings pressure from several fronts, with weak credit growth, falling net interest margins and rising compliance costs...
Shane Lee
742 Views
Share
bullish
•
Cross Asset Strategy
•
06 Feb 2019 12:56
Aussie Equities Month in Review (January 2019)
Australia underperformed the global benchmark in January but performed in line with the UK, Japan, and China. Beneficiaries of a weaker USD such...
Shane Lee
712 Views
Share
bullish
•
ResMed Inc
•
27 May 2026 06:01
ResMed (RMD AU) Vs. F&P Health (FPH AU): Earnings Jump Triggers Stat Arb Signal
8% target return in a potential pair trade after Fisher & Paykel Health’s earnings jump pushed the healthcare spread beyond a two-standard...
Gaudenz Schneider
Follow
167 Views
Share
bullish
•
Cross Asset Strategy
•
05 Dec 2018 06:37
Aussie Equities 2019: On a Wing and a Prayer
We expect 2019 will be challenging. Offshore macro and Geopolitical issues emerged in 2018 to dash our expectations of a good year for the Aussie...
Shane Lee
661 Views
Share
bullish
•
ICICI Prudential Life Insurance
•
25 May 2026 04:30
Relative Value Opportunities in Asia-Pac, Pair Trade Roundup (25 May 2026)
Discover 18 pair trade opportunities across four markets and seven sectors using statistical mean-reversion methodology for actionable insights.
Gaudenz Schneider
Follow
123 Views
Share
First
Previous
6
7
8
9
10
11
12
Next
Last
For Institutional Investors and Financial Services
For Corporate IR and Strategy
For Private Wealth Intermediaries
Pricing
How Smartkarma Compares
Who We Are
Careers
FAQs
Research Provider Solutions
Syndicate your Publications
Compliance
Terms of Use
Privacy Policy
Press Kit
RSS Feeds
Request a Free Trial
Avail a Transition Account
Guest Posts on Smartkarma
Other Enquiries
Join TL;DR Community
Free Weekly Newsletters
Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.70.5
x